4//SEC Filing
HOMCY CHARLES J 4
Accession 0000950170-25-089648
CIK 0001743881other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:56 PM ET
Size
7.4 KB
Accession
0000950170-25-089648
Insider Transaction Report
Form 4
HOMCY CHARLES J
Director
Transactions
- Award
Common Stock
2025-06-20+6,589→ 1,236,674 total - Award
Stock Option (Right to Buy)
2025-06-20+8,425→ 8,425 totalExercise: $41.73Exp: 2035-06-19→ Common Stock (8,425 underlying)
Footnotes (3)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. One-third of the RSUs will vest each year after June 20, 2025, such that all of the units will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001192591
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 6:56 PM ET
- Size
- 7.4 KB